Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Using cheek skin and cartilage grafts for nose reconstruction after skin cancer surgery can maintain shape and function but may require multiple surgeries and hair removal in men.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Lentiginous melanoma is most common on the face, especially the nose, cheek, and pre-auricular areas, with men more likely to have it on the scalp, ears, upper back, and trapezius, and women on the cheek and anterior arm. Sun damage is a key factor in its formation.

Trichopigmentation is a non-invasive, reversible treatment for hair loss that offers natural-looking results for both men and women.

Some treatments like minoxidil, finasteride, and dutasteride are effective for hair loss, but there's no agreed best treatment.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Men are an untapped market for facial cosmetic procedures, with a rise in nonsurgical treatments and potential for growth in older age groups.

Toupees improved perceived attractiveness, especially by older people, but had little effect on perceived self-assurance and health.

Serenoa repens extract may help hair growth in both men and women.

71 genetic markers explain 38% of male-pattern baldness risk.

Estrogen treatments can cause unwanted effects in men and should be used cautiously.

Male pattern baldness is mainly caused by genetics and hormones, treatable with minoxidil and finasteride.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

New genetic insights have improved understanding of hair loss, leading to a new test and treatments, but more research is needed on the test and laser comb effectiveness.

The hair fiber filler product increased satisfaction and improved quality of life for people with thinning hair.

IsoPSA test works accurately even if patients take certain prostate medications.

Oral minoxidil improved hair loss more than oral dutasteride.

Scalp tissue micrografts can effectively treat hair loss by increasing hair density and thickness.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Different ethnic hair traits must be considered for successful hair restoration surgery to achieve natural-looking results.

Your genes, especially IL-1a, can predict how well a hair growth treatment with platelet rich plasma will work for you.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.